GleamWall
中文EN

ATHE ALTERITY THERAPEUTICS LTD IFRS Annual reports only

Pharmaceutical Preparations · Nasdaq · SEC CIK 1131343 · Reporting currency AUD · Fiscal year ends 06/30

Financial factors as of 2018-06-30 (FY2018), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY51.9%
TTM net income YoY-9.6%
TTM EPS YoY-9.9%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin-4,108.8%
FCF margin-3,135.4%
EBITDA margin—

Returns

ROE-41.6%
ROA-37.6%
ROIC (approx.)—
Asset turnover0.01x

Leverage & solvency

Liabilities / assets14.1%
Debt / equity0.00x
Current ratio7.06x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.76x
Accruals ratio-9.2%
Payout ratio—
Capex / revenue31.0%

Factor history charts and full statement history on Pro 🔒

Financial statements

Annual Quarterly (none) Export CSV 🔒
Unit: AUD FY2025*2025-06-30FY2024*2024-06-30
Income statement
Revenue——
R&D expense14.40M18.64M
SG&A expense5.48M4.76M
Interest expense6,1887,217
Pretax income-12.08M-19.08M
Income tax68,05546,088
Net income-12.15M-19.12M
EPS (basic)-0.19-0.52
EPS (diluted)-0.19-0.52
Weighted avg. shares (diluted)6.40B3.65B
Balance sheet
Cash & equivalents33.16M12.64M
Receivables3.94M4.04M
Current assets45.87M19.04M
PP&E, netmay include right-of-use assets (IFRS)3,84832,154
Total assets46.03M19.22M
Current liabilities3.53M5.37M
Total liabilities3.62M5.43M
Shareholders' equity-225.89M-214.16M
Cash flow statement
Operating cash flow-11.45M-12.61M
Capital expenditure—5,722
Free cash flow—-12.61M
Investing cash flow-7.50M-5,722
Financing cash flow39.67M9.22M
Stock-based compensation979,920881,950

Free plan shows the latest 2 periods; Pro shows all 10 🔒

· This company reports under IFRS: some line items differ from US GAAP — operating income is not required, interest expense may be broader "finance costs", and banks have no standard revenue line.

· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.

· This company does not report gross profit in XBRL.

· Amounts are in the company's reporting currency, AUD, not USD; the site does no currency conversion.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.